Skip to main content

Transgenomic Gets California OK for Clinical Lab

NEW YORK (GenomeWeb News) – California health officials have cleared Transgenomic to offer its molecular lab services in the state by certifying its lab, the company said today.

The company said it expects to start marketing a number of its services to California doctors right away, including tests for mitochondrial disorders, oncology, hematology, molecular pathology, and inherited diseases.

The company said its lab is CLIA certified, is compliant with Good Laboratory Practices, and is accredited by the College of American Pathologists.

Company CEO Craig Tuttle said in a statement that Transgenomic underwent a "rigorous certification process" to obtain the state license. "The state of California represents the largest market opportunity in the United States" for the company's molecular lab testing services, he added.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.